Elon's Greatest Invention... Hidden in South Memphis?

In South Memphis, I uncovered what could be Elon Musk's biggest invention yet. It's so secretive, rivals are flying drones to spy on it. If you're serious about investing in AI, now's the time to see what's really going on inside those walls.

Do as I say, not as I do: On my failings as an investor

Christine Benz of Morningstar
July 15, 2025

If a knowledgeable observer trained his or her sights on my choices, what are the trouble spots they would identify? Here are some of the biggies.

I hold too much employer stock

I understand the tax implications of this, so I might as well sell each lot of restricted stock units as soon as it vests because there's no tax benefit to hanging on longer. And it's not like I think I possess some inside knowledge that the shares are likely to outperform the broad market.

Instead, the key culprit here is inertia. There's a little bit of tax dread mixed in, too, as selling them would trigger a big tax bill. I've been in the process of divesting from company stock for the past several years, but the allocation is still high.

I hold too much cash

Even when cash yields are higher, as they are today, inflation still gobbles up most of the interest.

Cash has stacked up in our account following bonuses or other windfalls, or during fallow spending periods like 2020. And it just never feels like an especially great time to move the money into long-term investments.

Perhaps most important, having cash on hand confers valuable peace of mind. I like knowing that almost anything could happen, and we'd be able to cover it without touching our long-term investments. I think of cash as one of my luxury goods.

I don't hold much in bonds

My husband and I should have a good slug of retirement assets in fixed-income investments at our life stage. But our portfolio is oddly barbelled, with a healthy dose of cash alongside a long-term portfolio that'smainly invested in equities.

In a way, I think the cash and the equities work together from a psychological perspective, with the liquid assets giving us peace of mind to stay the course with stocks.

But the lack of bonds isn't really deliberate. Instead, inertia is probably the main reason. We set up our long-term portfolios with heavy equity allocations in our 30s, and we've never really wavered. But this is something that I'd like to address as retirement approaches.

I don't have a perfect record with 'asset location'

There's a fantastic fund I own--but in our taxable brokerage account. If I could do it again, I'd buy this fund in a tax-sheltered account, because it has made some significant capital gains distributions over the years, which have boosted our household's annual tax bills.

Asset-location problems can be difficult to fix. Even though our reinvested capital gains have helped boost our cost basis, we would still owe a big tax bill if we liquidated the position because of the fund's gains.

I'm slow to make IRA contributions

Ideally, IRA contributions would go in right around the first of the year, to benefit from tax-sheltered compounding for a longer period. And our IRAs sit right alongside our taxable brokerage account, so transferring funds from the brokerage account to the IRA and converting them to Roth is simple.

But I've sometimes made those IRA contributions right before the deadline, a full 15 months later than when we were first eligible to make them. I've also been slow to make the conversions to Roth, periodically letting a few years' worth of contributions stack up in our IRAs before converting.

The baby bear market of March 2020 provided a good opportunity to convert all the traditional IRA assets to Roth with no tax repercussions. I've been walking the straight and narrow--with timely contributions and conversions --ever since.

___

This article was provided to The Associated Press by Morningstar. For more personal finance content, go to https://www.morningstar.com/personal-finance

Christine Benz is director of personal finance for Morningstar.

Continue Reading...

Popular

Trump keeps saying the GOP mega bill will eliminate taxes on Social Security. It does not

WASHINGTON (AP) — President keeps saying that Republicans' mega legislation will eliminate taxes on federal benefits.

Social Security Administration Sends 'Unbelievable' Email On Trump's 'Big, Beautiful Bill': Report

Email from SSA claims Trump's tax law will eliminate taxes on Social Security benefit. Critics call it politically motivated and incorrect.

Back This Medical AI Tech - Ad

You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.

Trump asks Supreme Court to remove 3 Democrats on the Consumer Product Safety Commission

WASHINGTON (AP) — The Trump administration on Wednesday asked the to remove three Democratic members of the , who were fired by President and then reinstated by a federal judge.

Elon Musk Renews Demand for Jeffrey Epstein Files Release, Weeks After Alleging Trump Is Named in Them

Elon Musk has once again demanded the release of the unredacted Jeffrey Epstein files. This comes in the wake of his allegations against President Trump.

Trump Exec Order to Help Restore Wealth for American Citizens? - Ad

Thanks to President Trump's Executive Order 14179, a brief "AI Wealth Window" is opening now. Genius investor James Altucher has released 3 AI wealth-building strategies to take advantage of Trump's genius Executive Order 14179. James believes you could see $10,000 grow to $1 MILLION or more over the next few years.

Paramount to pay $16 million in settlement with Trump over '60 Minutes' interview

In a case seen as a challenge to free speech, Paramount has agreed to pay $16 million to settle a lawsuit filed by President Donald Trump over the editing of CBS' “60 Minutes” interview with then-Vice President Kamala Harris in October.

Alibaba Prices $1.5 Billion Via Zero-Coupon Bonds To Fund AI, Cloud Push

Alibaba announced $1.5B bond offering for AI and cloud expansion, exchangeable for shares of Alibaba Health. Expected to close July 9.

Have You Seen this Strange Elon Musk Device? - Ad

Tech legend Jeff Brown predicts this "space technology" will be Elon Musk's next trillion-dollar business, and it will make a lot of people rich. This could be the biggest internet innovation since the first web browser Netscape kicked off the internet boom in the late 1990s.

Greed Mode On: Why Tesla, Nvidia, Palantir And Bitcoin Plays Could Rip

The stock market's buzzing with euphoria, with the CNN Business Fear & Greed Index at 78—"Extreme Greed" for the first time since March 2024.

'Tesla Has The Robot And The Customer': Dave Mazza's HUMN ETF Makes A Calculated Bet On Optimus

Investors are seeking exposure to the $5 trillion humanoid robotics market and Roundhill's HUMN ETF offers active management for agility and alpha generation.

Is Elon's Empire Crumbling? - Ad

Jeff Brown - the legend who called Tesla and Nvidia early - says Elon is about to launch a $25T AI revolution. This isn't another chatbot. It's real-world AI that could 14X the impact of ChatGPT. But after July 23rd, it may be too late.

Mexican banks face cascading consequences following US sanctions

Mexico City (AP) — Three Mexican financial institutions sanctioned by the Trump administration last week have felt a cascade of economic consequences following the allegations that they helped launder millions of dollars for drug cartels.

FDA Submission Expected This Summer - Invest Before It Happens - Ad

This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.

Joe Rogan Once Said He Started Doubting The Apollo Missions After COVID-19, Compared Post-Flight Press Conference To A 'Hostage Video'

Joe Rogan told Matt Walsh he began doubting the moon landing after COVID, while Walsh argued that faking the Apollo missions would have been even more unbelievable than achieving them.

Nations are meeting to drum up trillions to combat poverty — but the US isn't going

UNITED NATIONS (AP) — Many of the world’s nations are gathering starting Monday in Spain for a high-level conference to tackle the and try to drum up trillions of dollars needed to close it. The United States, previously a major contributor, pulled its participation, so finding funding will be tough.

How to Hack a $1.3T Market - Ad

Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Their tech unlocks a $1.3T real estate market. They've already earned $110M+ in gross profits in their operating history and reserved the Nasdaq ticker PCSO.

OpenAI Says Tokens Are Not Equity, No Partnership With Robinhood: Musk Says AI Company's Equity 'Is Fake'

OpenAI says the "OpenAI tokens" offered by Robinhood are not OpenAI equity and clarified that it has no partnership or involvement with Robinhood.

Elon's New Device Could Launch Biggest IPO of the Decade - Ad

Elon Musk's new device is being called a "game-changer"-and even the White House is using this tech. Jeff Brown says it could launch Musk's next trillion-dollar company and make early investors rich. You can claim a stake now for as little as $500.

Amazon's AI-Powered 4-Day Prime Day Will Drive Billions In Sales

Bank of America analyst maintains Buy rating on Amazon with $248 price forecast, noting 11th Prime Day event to have extended 4-day window with AI savings tools and estimated $21.4B in GMV.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.

Sonnet BioTherapeutics Drops 5% Intraday, Rebounds 14% After Hours Amid Delisting Concerns

Sonnet BioTherapeutics Holdings Inc. (NASDAQ: SONN) fell 5.54% on Thursday to close at $3.92, before rebounding 14.29% in after-hours trading to $4.48, amid concerns of a potential NASDAQ delisting.

Gold, Bitcoin Surge As Trump Eyes Powell Ouster: What's Moving Markets Wednesday?

Volatility surged across interest rate-sensitive assets Wednesday after reports circulated that President Donald Trump may be preparing to remove Federal Reserve Chair Jerome Powell from his post. The rumors sparked fears over the Fed's independ

Putting Your Name on This List Could Hand You $1,270 on Friday - Ad

URGENT: On Tuesday, a simple set of instructions will be sent out to an elite group of investors. The folks in this group will have the opportunity to place a 10-minute trade that could double their money by Friday. Consider this your invitation to join them. The next trade is just days away.

Shares in Asia are mixed amid Trump's new tariff deadlines

Shares were mixed in Asia on Wednesday, following a choppy trading day on Wall Street as the Trump administration pressed its campaign to win more favorable trade deals with nations around the globe.

Elon's Greatest Invention... Hidden in South Memphis? - Ad

In South Memphis, I uncovered what could be Elon Musk's biggest invention yet. It's so secretive, rivals are flying drones to spy on it. If you're serious about investing in AI, now's the time to see what's really going on inside those walls.

FDA vaccine official restricted COVID vaccine approvals against the advice of agency staff

WASHINGTON (AP) — The working under Health Secretary recently of two COVID-19 vaccines, disregarding recommendations from government scientists, according to federal documents released Wednesday.

Apple Has the Potential To Crush Meta's Ray-Ban Smart Glasses, Says Ming-Chi Kuo, But The Tech Giant Has Been 'Surprisingly Slow'

Analyst Ming-Chi Kuo believes Apple has the potential to surpass Meta's Ray-Ban smart glasses, but notes the company's slow progress in this market could delay its dominance.

Back This Medical AI Tech - Ad

You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.

BlackRock's Bitcoin ETF Surpasses S&P 500 ETF In Revenue As XRP, Dogecoin ETF Approval Predicted To Follow Soon

The momentum behind spot crypto ETFs is accelerating, as inflows and revenues from Bitcoin (CRYPTO: BTC) and Ethereum (CRYPTO: ETH) ETFs have outpaced traditional

Trump Exec Order to Help Restore Wealth for American Citizens? - Ad

Thanks to President Trump's Executive Order 14179, a brief "AI Wealth Window" is opening now. Genius investor James Altucher has released 3 AI wealth-building strategies to take advantage of Trump's genius Executive Order 14179. James believes you could see $10,000 grow to $1 MILLION or more over the next few years.

20 Surprising Reddit Facts To Celebrate Its Milestone Birthday

Here's a look at Reddit's best-kept secrets and odd historical footnotes as the platform turns 20.

'Lord of the Rings' director backs long shot de-extinction plan, starring New Zealand's lost moa

WASHINGTON (AP) — Filmmaker owns one of the largest private collections of bones of an extinct New Zealand bird called the moa. His fascination with the flightless ostrich-like bird has led to an unusual partnership with a biotech company known for its grand and controversial plans to bring back lost species.

Have You Seen this Strange Elon Musk Device? - Ad

Tech legend Jeff Brown predicts this "space technology" will be Elon Musk's next trillion-dollar business, and it will make a lot of people rich. This could be the biggest internet innovation since the first web browser Netscape kicked off the internet boom in the late 1990s.

AstraZeneca In $15 Billion Talks For Drug That Could Upend Lung Cancer Treatment

AstraZeneca is in advanced talks with Summit Therapeutics over a potential $15 billion deal for the lung cancer drug ivonescimab.

Trending Now

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright activatrade.ca
Privacy Policy | Terms of Service